| Primary |
| Contraception |
48.4% |
| Product Used For Unknown Indication |
12.4% |
| Oral Contraception |
8.8% |
| Pain |
6.9% |
| Drug Use For Unknown Indication |
6.5% |
| Menstruation Irregular |
2.8% |
| Menorrhagia |
2.3% |
| Depression |
1.8% |
| Epilepsy |
1.8% |
| Injectable Contraception |
1.4% |
| Acute Leukaemia |
0.9% |
| Dysmenorrhoea |
0.9% |
| Foetal Exposure During Pregnancy |
0.9% |
| Oral Herpes |
0.9% |
| Thyroid Disorder |
0.9% |
| Agitation |
0.5% |
| Bacterial Infection |
0.5% |
| Constipation |
0.5% |
| Drug Use For Unknown Indication |
0.5% |
| Food Allergy |
0.5% |
|
| Pregnancy On Oral Contraceptive |
17.0% |
| Maternal Exposure During Pregnancy |
15.1% |
| Product Quality Issue |
14.2% |
| Drug Ineffective |
8.5% |
| Drug Interaction |
4.7% |
| Off Label Use |
4.7% |
| Unintended Pregnancy |
4.7% |
| Anxiety |
2.8% |
| Metrorrhagia |
2.8% |
| Pancreatitis |
2.8% |
| Proctocolectomy |
2.8% |
| Pulmonary Embolism |
2.8% |
| Thrombosis |
2.8% |
| Weight Increased |
2.8% |
| Blood Urine Present |
1.9% |
| Cerebrovascular Accident |
1.9% |
| Colitis Ulcerative |
1.9% |
| Deep Vein Thrombosis |
1.9% |
| Depression |
1.9% |
| Gallbladder Disorder |
1.9% |
|
| Secondary |
| Contraception |
33.3% |
| Pain |
27.3% |
| Depression |
13.6% |
| Acute Lymphocytic Leukaemia |
7.6% |
| Menstruation Irregular |
6.1% |
| Migraine |
3.0% |
| Oral Herpes |
3.0% |
| Bacterial Infection |
1.5% |
| Drug Use For Unknown Indication |
1.5% |
| Oral Contraception |
1.5% |
| Prophylaxis |
1.5% |
|
| Dysfunctional Uterine Bleeding |
11.1% |
| Pregnancy |
11.1% |
| Drug Interaction |
7.4% |
| Metrorrhagia |
7.4% |
| Pregnancy On Oral Contraceptive |
7.4% |
| Thrombosis |
7.4% |
| Blood Urine Present |
3.7% |
| Cerebrovascular Accident |
3.7% |
| Contraindication To Medical Treatment |
3.7% |
| Embolism |
3.7% |
| Maternal Exposure During Pregnancy |
3.7% |
| Micturition Disorder |
3.7% |
| Migraine |
3.7% |
| Off Label Use |
3.7% |
| Product Quality Issue |
3.7% |
| Product Substitution Issue |
3.7% |
| Pulmonary Embolism |
3.7% |
| Rash |
3.7% |
| Unintended Pregnancy |
3.7% |
|
| Concomitant |
| Contraception |
23.1% |
| Drug Use For Unknown Indication |
9.2% |
| Product Used For Unknown Indication |
6.9% |
| Anxiety |
6.5% |
| Oral Contraception |
6.2% |
| Crohn's Disease |
5.5% |
| Acne |
5.0% |
| Depression |
4.2% |
| Cough |
3.2% |
| Menorrhagia |
3.2% |
| Post Coital Contraception |
3.2% |
| Rheumatoid Arthritis |
3.2% |
| Colitis Ulcerative |
3.0% |
| Psoriatic Arthropathy |
2.7% |
| Asthma |
2.5% |
| Hypersensitivity |
2.5% |
| Hypertension |
2.5% |
| Menstruation Irregular |
2.5% |
| Pain |
2.5% |
| Premenstrual Syndrome |
2.5% |
|
| Abdominal Pain |
10.3% |
| Deep Vein Thrombosis |
8.8% |
| Pain |
7.4% |
| Vomiting |
7.4% |
| Chest Pain |
5.9% |
| Menstruation Irregular |
5.9% |
| Cholelithiasis |
4.4% |
| Drug Effect Decreased |
4.4% |
| Injection Site Swelling |
4.4% |
| Nausea |
4.4% |
| Ovarian Cyst |
4.4% |
| Pregnancy |
4.4% |
| Staphylococcal Infection |
4.4% |
| Unintended Pregnancy |
4.4% |
| Weight Increased |
4.4% |
| Abdominal Pain Upper |
2.9% |
| Accident |
2.9% |
| Accidental Exposure |
2.9% |
| Adnexa Uteri Pain |
2.9% |
| Anaemia |
2.9% |
|
| Interacting |
| Pain |
56.3% |
| Contraception |
25.0% |
| Acne |
6.3% |
| Schizophrenia |
6.3% |
| Smoking Cessation Therapy |
6.3% |
|
| Drug Ineffective |
20.0% |
| Drug Interaction |
20.0% |
| Hyperkinesia |
20.0% |
| Metrorrhagia |
20.0% |
| Pregnancy |
20.0% |
|
